FEMOSTON CONTI 15 TABLET Сингапур - Енглески - HSA (Health Sciences Authority)

femoston conti 15 tablet

abbott laboratories (singapore ) private limited - dydrogesterone micronized; estradiol hemihydrate 1.03 mg eqv estradiol (micronised) - tablet, film coated - 5 mg - dydrogesterone micronized 5 mg; estradiol hemihydrate 1.03 mg eqv estradiol (micronised) 1 mg

FEMOSTON-CONTI tablet blister pack Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

femoston-conti tablet blister pack

viatris pty ltd - estradiol, quantity: 1 mg (equivalent: estradiol hemihydrate, qty 1.03 mg); dydrogesterone, quantity: 5 mg - tablet, film coated - excipient ingredients: lactose monohydrate; maize starch; hypromellose; magnesium stearate; colloidal anhydrous silica; titanium dioxide; iron oxide yellow; iron oxide red; macrogol 400 - hormone replacement therapy (hrt) in oestrogen deficiency associated with natural or artificial menopause in women with an intact uteri. prevention of postmenopausal bone mineral density loss in women. for initiation and continuation of treatment of postmenopausal symptoms, the lowest possible effective dose for the shortest duration should be used with the goal being short term use.

Femoston conti Tablet, film coated 1mg/5mg Малта - Енглески - Malta Medicines Authority

femoston conti tablet, film coated 1mg/5mg

mylan products limited - dydrogesterone; estradiol - film-coated tablet - dydrogesterone 5 mg; estradiol 1 mg - sex hormones and modulators of the genital system

FEMOSTON 2 mg, 10 m Milligram Film Coated Tablet Ирска - Енглески - HPRA (Health Products Regulatory Authority)

femoston 2 mg, 10 m milligram film coated tablet

bgp products ltd - estradiol hemihydrate, dydrogesterone - film coated tablet - 2 mg, 10 m milligram - progestogens and estrogens, sequential preparations - sequential hormone replacement therapy - hormone replacement therapy (hrt) for estrogen deficiency symptoms in postmenopausal women at least 6 months since the last menses. prevention of osteoporosis in postmenopausal women at high risk of future fractures who are intolerant of, or contraindicated for, other medicinal products approved for the prevention of osteoporosis.

FEMOSTON 1 mg, 10 m Milligram Film Coated Tablet Ирска - Енглески - HPRA (Health Products Regulatory Authority)

femoston 1 mg, 10 m milligram film coated tablet

bgp products ltd - estradiol hemihydrate, dydrogesterone - film coated tablet - 1 mg, 10 m milligram - progestogens and estrogens, sequential preparations

FEMOSTON  CONTI 1/5 mg Tablets Кенија - Енглески - Pharmacy and Poisons Board

femoston conti 1/5 mg tablets

abbott laboratories s.a. (pty) ltd 219 golf club terrace constantia kloof , - oestradiol/ dydrogesterone - tablet - each film-coated tablet contains oestradiol… - hormonal contraceptives: progestogens for

FEMUREST-CONTI 1/5 Milligram Film Coated Tablet Ирска - Енглески - HPRA (Health Products Regulatory Authority)

femurest-conti 1/5 milligram film coated tablet

abbott healthcare products ltd - estradiol hemihydrate dydrogesterone - film coated tablet - 1/5 milligram

Femoston conti film-coated Tablets Малта - Енглески - Malta Medicines Authority

femoston conti film-coated tablets

abbott healthcare products limited - dydrogesterone 5 mg, estradiol 1 mg - film-coated tablet

FEMOSTON CONTI 0.5 MG2.5 MG Израел - Енглески - Ministry of Health

femoston conti 0.5 mg2.5 mg

abbott medical laboratories ltd, israel - dydrogesterone; estradiol as hemihydrate - film coated tablets - dydrogesterone 2.5 mg; estradiol as hemihydrate 0.5 mg - dydrogesterone and estrogen - hormone replacement therapy (hrt) for estrogen deficiency symptoms in postmenopausal women at least 12 months since last menses.femoston is indicated for women with an intact uterus

FEMOSTON CONTI 1 MG5 MG Израел - Енглески - Ministry of Health

femoston conti 1 mg5 mg

abbott medical laboratories ltd, israel - dydrogesterone; estradiol as hemihydrate - film coated tablets - dydrogesterone 5 mg; estradiol as hemihydrate 1 mg - dydrogesterone and estrogen - hormone replacement therapy (hrt) for estrogen deficiency symptoms in postmenopausal women at least 12 months since last menses.prevention of osteoporosis in postmenopausal women at high risk of future fractures. femoston contini 1/5 should only be used in patients who are intolerant of other products, approved for the prevention of osteoporosis or for whom these products are contra-indicated.femoston is indicated for women with an intact uterus